News GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Equities

GLAXO

INE159A01016

Market Closed - NSE India S.E. Other stock markets 07:40:45 2024-04-16 am EDT			5-day change	1st Jan Change
1,899 ^INR	-0.18%		-0.56%	+0.03%

Mar. 22	GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities	CI
Feb. 29	Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities	Mar. 22	CI
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	Feb. 28	MT
Glaxosmithkline Pharmaceuticals Limited Appoints Aparajita Mukherjee Rajput, Technology Lead	Feb. 28	CI
GlaxoSmithKline Pharmaceuticals Sees Sharp Decline in Fiscal Q3 Consolidated Net Profit	Feb. 13	MT
GSK India arm's Q3 profit falls on government price cap	Feb. 12	RE
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024	Dec. 29	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Abhinav Kashyap as Pharma Technology Lead	Dec. 06	CI
GSK registers 5% Growth	Nov. 10	AQ
GSK's India unit posts Q2 profit rise on strong vaccine demand	Nov. 09	RE
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
GlaxoSmithKline Pharmaceuticals Limited Appoints Omkar Parnandiwar as Head of Omnichannel, Effective November 1, 2023	23-10-31	CI
GSK - General Medicines delivers 4% revenue growth despite NLEM impact along with a sequential recovery in the vaccines business	23-07-27	AQ
Glaxosmithkline Pharmaceuticals Records Rise in Fiscal Q1 Consolidated Net Profit	23-07-27	MT
India's GlaxoSmithKline Pharma posts rise in Q1 profit on steady vaccine business	23-07-26	RE
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-26	CI
Samsung Biologics unveils $920 mln manufacturing deals for Pfizer	23-07-03	RE
Ex-dividend day for final dividend	23-06-29	FA
A son died, his parents tried to sue. How U.S. courts protect Big Pharma	23-06-26	RE
Abbott's India arm posts 9.5% rise in fourth-quarter profit	23-05-19	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Equities

GLAXO

INE159A01016

Summary

Filters